Literature DB >> 12020886

The global epidemiological situation of schistosomiasis and new approaches to control and research.

D Engels1, L Chitsulo, A Montresor, L Savioli.   

Abstract

While the distribution of schistosomiasis has changed over the last 50 years and there have been successful control programmes, the number of people estimated to be infected or at risk of infection has not been reduced. Today, 85% of the number of infected people are estimated to be on the African continent where few control efforts are made. In terms of disease burden, there is therefore a growing discrepancy between sub-Saharan Africa and the rest of the world. WHO has now developed a dual strategy for the control of schistosomiasis: a strategy for morbidity control adapted to the public health context in high burden areas, and a strategy to consolidate control in areas where a low endemic level has been reached and elimination may be feasible. Related to this new vision, some research needs are pointed out.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020886      PMCID: PMC5633073          DOI: 10.1016/s0001-706x(02)00045-1

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  21 in total

1.  Schistosoma haematobium in Morocco: moving from control to elimination.

Authors:  H Laamrani; J Mahjour; H Madsen; K Khallaayoune; B Gryseels
Journal:  Parasitol Today       Date:  2000-06

2.  Prevention and control of schistosomiasis and soil-transmitted helminthiasis.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2002

3.  From discovery to eradication of schistosomiasis in Japan: 1847-1996.

Authors:  H Tanaka; M Tsuji
Journal:  Int J Parasitol       Date:  1997-12       Impact factor: 3.981

Review 4.  The relevance of schistosomiasis for public health.

Authors:  B Gryseels
Journal:  Trop Med Parasitol       Date:  1989-06

5.  The control of schistosomiasis. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1985

6.  Praziquantel--quality, dosages and markers of resistance.

Authors:  C C Appleton; A Mbaye
Journal:  Trends Parasitol       Date:  2001-08

7.  Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania.

Authors:  C F Hatz; B J Vennervald; T Nkulila; P Vounatsou; Y Kombe; C Mayombana; H Mshinda; M Tanner
Journal:  Am J Trop Med Hyg       Date:  1998-11       Impact factor: 2.345

8.  Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa.

Authors:  Marieke J van der Werf; Sake J de Vlas; Simon Brooker; Caspar W N Looman; Nico J D Nagelkerke; J Dik F Habbema; Dirk Engels
Journal:  Acta Trop       Date:  2003-05       Impact factor: 3.112

9.  Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations.

Authors:  C H King; E M Muchiri; J H Ouma
Journal:  Mem Inst Oswaldo Cruz       Date:  1992       Impact factor: 2.743

10.  Schistosomiasis control in Brazil.

Authors:  N Katz
Journal:  Mem Inst Oswaldo Cruz       Date:  1998       Impact factor: 2.743

View more
  138 in total

Review 1.  Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.

Authors:  Jürg Utzinger; Jennifer Keiser; Xiao Shuhua; Marcel Tanner; Burton H Singer
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Evaluation of an IgY-based immunomagnetic enzyme-linked immunosorbent assay system for detection of circulating Schistosoma japonicum antigen in serum samples from patients in China.

Authors:  Jia-hui Lei; Bing-tao Su; Hong Xu; Ji-long Shen; Xiao-hong Guan; Zhen-qing Feng; Yong-long Li; Ming-xing Xu; Wen-qi Liu
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

Review 3.  Topical application of DEET for schistosomiasis.

Authors:  Kalyanasundaram Ramaswamy; Yi Xun He; Buz Salafsky; Takeshi Shibuya
Journal:  Trends Parasitol       Date:  2003-12

Review 4.  Applying evolutionary genetics to schistosome epidemiology.

Authors:  Michelle L Steinauer; Michael S Blouin; Charles D Criscione
Journal:  Infect Genet Evol       Date:  2010-02-20       Impact factor: 3.342

5.  Acute abdomen associated with schistosomiasis of the appendix.

Authors:  Chiara Gabbi; Marco Bertolotti; Rossella Iori; Francesco Rivasi; Claudio Stanzani; Mauro Maurantonio; Nicola Carulli
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

6.  Up-converting phosphor technology-based lateral flow assay for detection of Schistosoma circulating anodic antigen in serum.

Authors:  Paul L A M Corstjens; Lisette van Lieshout; Michel Zuiderwijk; Dieuwke Kornelis; Hans J Tanke; Andre M Deelder; Govert J van Dam
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

7.  Prevalence and distribution of Schistosoma haematobium infection among school children living in southwestern shores of Lake Malawi.

Authors:  Sekeleghe Kayuni; Rosanna Peeling; Peter Makaula
Journal:  Malawi Med J       Date:  2017-03       Impact factor: 0.875

8.  Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage.

Authors:  Rosemary M Cook; Claudia Carvalho-Queiroz; Gregory Wilding; Philip T LoVerde
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Schistosomiasis and neglected tropical diseases: towards integrated and sustainable control and a word of caution.

Authors:  J Utzinger; G Raso; S Brooker; D De Savigny; M Tanner; N Ornbjerg; B H Singer; E K N'goran
Journal:  Parasitology       Date:  2009-11       Impact factor: 3.234

10.  Cost-effectiveness of a successful schistosomiasis control programme in Cambodia (1995-2006).

Authors:  Davide Croce; Emanuele Porazzi; Emanuela Foglia; Umberto Restelli; Muth Sinuon; Duong Socheat; Antonio Montresor
Journal:  Acta Trop       Date:  2009-12-03       Impact factor: 3.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.